CHA Vaccine Research Institute (KOSDAQ: 261780)

CHA Vaccine Research Institute Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	12,003	5,906	2,386	3,955	11,838	2,672
Short-Term Investments	25,990	32,990	55,377	47,500	3,000	3,158
Trading Asset Securities	-	-	-	10,095	9,989	3,047
Cash & Short-Term Investments	37,993	38,896	57,763	61,550	24,827	8,878
Cash Growth	-28.37%	-32.66%	-6.15%	147.92%	179.65%	1339.71%
Accounts Receivable	0	0	-0	-0	-0	0
Other Receivables	1,024	453.87	607.81	266.9	188.2	146.64
Receivables	1,024	453.87	607.8	266.9	188.2	146.64
Prepaid Expenses	86.3	94.23	117.1	12.94	8.52	3.14
Other Current Assets	9,403	3,042	429	17.07	13.91	9.98
Total Current Assets	48,506	42,486	58,917	61,847	25,037	9,038
Property, Plant & Equipment	1,421	1,644	1,543	1,032	586.81	355.22
Long-Term Investments	674.6	674.6	440	2,300	-	-
Other Intangible Assets	99.14	43.58	39.91	21.77	28.86	42.41
Long-Term Accounts Receivable	0	0	0	0	0	0
Other Long-Term Assets	326.35	270.9	129.08	112.5	94.43	121.02
Total Assets	51,027	45,119	61,069	65,313	25,747	9,556
Accounts Payable	-	-	-	-	-	50.16
Accrued Expenses	141.36	146.74	77.43	60.77	63	20.63
Short-Term Debt	-	-	23,240	20,717	-	3,000
Current Portion of Leases	179.1	162.92	381.21	112.8	101.77	6.46
Other Current Liabilities	486.68	500.53	3,090	3,816	4,641	12,182
Total Current Liabilities	807.14	810.18	26,789	24,706	4,806	15,259
Long-Term Debt	9,088	3,975	-	-	18,610	2,219
Long-Term Leases	199.99	188.65	16.53	16.14	128.94	2.31
Other Long-Term Liabilities	6,953	3,525	15.09	237.52	186.68	461.79
Total Liabilities	18,338	9,702	27,703	25,698	24,174	18,382
Common Stock	13,412	13,366	13,215	13,215	11,194	8,894
Additional Paid-In Capital	80,185	76,782	72,576	72,576	18,404	4,409
Retained Earnings	-61,430	-55,457	-53,615	-46,921	-28,335	-22,149
Comprehensive Income & Other	522.32	725.68	1,190	745.6	310.07	20.04
Shareholders' Equity	32,689	35,417	33,366	39,615	1,573	-8,826
Total Liabilities & Equity	51,027	45,119	61,069	65,313	25,747	9,556
Total Debt	9,467	4,327	23,638	20,846	18,840	5,227
Net Cash (Debt)	28,526	34,569	34,125	40,704	5,986	3,650
Net Cash Growth	3.59%	1.30%	-16.16%	579.94%	64.00%	-
Net Cash Per Share	1067.99	1298.66	1290.78	1745.71	333.84	-
Filing Date Shares Outstanding	26.82	26.73	26.43	26.43	17.93	-
Total Common Shares Outstanding	26.82	26.73	26.43	26.43	17.93	-
Working Capital	47,699	41,676	32,128	37,141	20,231	-6,222
Book Value Per Share	1218.63	1324.89	1262.45	1498.91	87.72	-
Tangible Book Value	32,590	35,373	33,326	39,593	1,544	-8,868
Tangible Book Value Per Share	1214.93	1323.26	1260.94	1498.09	86.11	-
Land	95.09	95.09	95.09	95.09	95.09	67.72
Buildings	402.68	402.68	402.68	402.68	402.68	286.59
Machinery	2,084	1,933	1,622	1,079	410.3	357.17

Source: S&P Capital IQ. Standard template. Financial Sources.